Cervical cancer rates and deaths are increasing around the world, with the highest rates in sub-Saharan Africa.

New research identifies molecular signatures in SCLC that could improve immunotherapy outcome prediction beyond conventional staging.

Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy cells.

The study followed 4,190 adults with stage 2 hypertension in Pakistan for 12 months, who had their blood pressure continuously monitored using a wrist-worn fitness tracker.

A 12-year study of more than 52,000 women finds no increased cardiovascular risk with modern hormone replacement therapy started during midlife.

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, ...

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...